HARBOURVEST PARTNERS LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$567,348
-39.2%
335,7090.0%0.19%
-27.2%
Q2 2023$933,271
+52.7%
335,7090.0%0.26%
+28.6%
Q1 2023$610,990
-64.1%
335,7090.0%0.21%
-63.9%
Q4 2022$1,702,045
+2.0%
335,7090.0%0.57%
+4.6%
Q3 2022$1,668,000
+33.5%
335,7090.0%0.54%
+32.9%
Q2 2022$1,249,000
-33.7%
335,7090.0%0.41%
+6.8%
Q1 2022$1,883,000
-7.7%
335,7090.0%0.38%
+47.1%
Q4 2021$2,041,000
-37.6%
335,7090.0%0.26%
-15.0%
Q3 2021$3,270,000
-31.8%
335,7090.0%0.31%
-33.0%
Q2 2021$4,794,000
-41.8%
335,709
-3.3%
0.46%
-58.6%
Q1 2021$8,238,000347,0091.10%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders